USA - NASDAQ:NEPH - US6406714005 - Common Stock
The current stock price of NEPH is 4.92 USD. In the past month the price decreased by -4.28%. In the past year, price increased by 225.83%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PH | PARKER HANNIFIN CORP | 28.87 | 103.69B | ||
| ITW | ILLINOIS TOOL WORKS | 23.39 | 70.28B | ||
| OTIS | OTIS WORLDWIDE CORP | 21.99 | 34.09B | ||
| XYL | XYLEM INC | 28.52 | 33.60B | ||
| SYM | SYMBOTIC INC | 364.8 | 32.31B | ||
| IR | INGERSOLL-RAND INC | 23.15 | 29.63B | ||
| DOV | DOVER CORP | 19.12 | 24.41B | ||
| SNA | SNAP-ON INC | 17.37 | 17.23B | ||
| FTV | FORTIVE CORP | 15.5 | 17.20B | ||
| ITT | ITT INC | 28.08 | 13.95B | ||
| RBC | RBC BEARINGS INC | 39.28 | 13.50B | ||
| GGG | GRACO INC | 28.26 | 13.20B |
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 31 full-time employees. The company went IPO on 2004-09-21. The firm provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
NEPHROS INC
380 Lackawanna Pl
South Orange NEW JERSEY 07079 US
CEO: Andrew Astor
Employees: 31
Phone: 12013435202
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 31 full-time employees. The company went IPO on 2004-09-21. The firm provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
The current stock price of NEPH is 4.92 USD. The price decreased by -2.19% in the last trading session.
NEPH does not pay a dividend.
NEPH has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
NEPHROS INC (NEPH) currently has 31 employees.
NEPHROS INC (NEPH) has a market capitalization of 52.15M USD. This makes NEPH a Micro Cap stock.
The outstanding short interest for NEPHROS INC (NEPH) is 0.11% of its float.
ChartMill assigns a technical rating of 9 / 10 to NEPH. When comparing the yearly performance of all stocks, NEPH is one of the better performing stocks in the market, outperforming 98.08% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to NEPH. While NEPH has a great health rating, its profitability is only average at the moment.
Over the last trailing twelve months NEPH reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS increased by 244.44% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.95% | ||
| ROA | 10.84% | ||
| ROE | 13.82% | ||
| Debt/Equity | 0 |
8 analysts have analysed NEPH and the average price target is 5.61 USD. This implies a price increase of 14.02% is expected in the next year compared to the current price of 4.92.
For the next year, analysts expect an EPS growth of 1322977426536356900% and a revenue growth 24.58% for NEPH